Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia

Complements Alira Health’s Established US and EU Mediterranean Clinical Operations with a Strong Central European Presence

FRAMINGHAM, Mass. – April 5, 2022– Alira Health, a global health care advisory and technology company, announced that it has acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and digital therapeutics. Founded in 2012, Sourcia is based in Europe, with headquarters in Zevenbergen, The Netherlands, and operational offices in Munich, Germany, and Vienna, Austria.

Benjamin Chambon

Benjamin Chambon

CCO and Co-Founder,

Alira Health

The increasing need for time-efficient and cost-effective drug development is driving demand for CRO services.  We believe that Sourcia’s integrated outsourcing model is particularly suited to the needs of today’s market,” said Benjamin Chambon, Chief Commercial Officer of Alira Health. “Sourcia is a well-established player in the European CRO market with a deeply experienced leadership team and a strong reputation in the VC community for a pattern of innovation. We are incredibly honored to welcome them to Alira Health.”

Verena Koepke

Managing Partner, Sourcia

 

Sourcia’s unique integrated outsourcing model lets biotech and MedTech clients manage clinical trials with the highest level of effectiveness, efficiency, and trust”, said Verena Koepke, Managing Partner of Sourcia. “We are extremely pleased to become part of Alira Health and expand our capabilities of full-service clinical work. Alira Health’s broad range of tech-enabled consulting and advisory services, complemented by its mission to humanize healthcare, is where our industry is headed.”

About Sourcia

Sourcia founded in 2012, is a Contract Research Organization, that specifically focuses on providing clinical trial services for Phase I to Phase IV / Pre- and Post CE marking-related clinical trials. Sourcia is located in Europe with its Headquarters in Zevenbergen, The Netherlands, and with its operational offices in Munich, Germany, and Vienna, Austria. Sourcia’s target is to focus on small-to-medium-sized biotech and medical device companies located in Europe. The team has years of practical experience and will support its clients on the road to success by finding the best-unbiased outsourcing solution for them and their businesses.

Learn more at www.sourcia.eu.

 

Related news

Events February 2, 2023
ACDM 2023
We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)
Clinical Data Science
Publications February 2, 2023
Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’
In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.
MedTech Pharma
News January 31, 2023
The Playbook for Patient Engagement in MedTech in the U.S. is Launched
The MedTech Patient Engagement Think Tank announced today the launch of the Playbook for Patient Engagement in MedTech in the U.S.
MedTech Patient Engagement
Publications January 31, 2023
A Playbook for Patient Engagement in MedTech in the U.S.
“A Playbook for Patient Engagement in MedTech in the U.S.” is a result of amalgamating ideas, research, findings, and forecasts from industry subject matter experts that together(...)
MedTech Patient Engagement
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications January 19, 2023
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Medical Devices MedTech Regulatory
News January 19, 2023
Alira Health Appoints Annabel de Maria Chief Patient Officer, Leading Global Patient Partnerships
Alira Health is pleased to announce today the appointment of Annabel de Maria as Chief Patient Officer. In this leadership capacity, she will spearhead the central role of patient engagement(...)
Patient Advocacy Patient Centric Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.